Perrigo Changes Reporting Structure In Latest Stop On Cost-Cutting Trail
This article was originally published in The Pink Sheet
Executive Summary
Perrigo reorganizes its reporting segments to better align with its organizational structure; consumer product units are combined and renamed.
You may also be interested in...
Perrigo Starts Branded Consumer Product Rescue Mission In Belgium
Perrigo is restructuring its OTC drug and nutritional product businesses in Belgium – Omega Pharma Belgium NV, Etixx NV and Biover NV – and expects changes will eliminate between 45 and 80 jobs.
Perrigo Puts Tysabri On Block, Generic Topicals Under Microscope
A portfolio review concluded that 'the next step to unlock shareholder value is … exploring strategic alternatives for that Tysabri royalty stream,' CEO John Hendrickson said during Perrigo's third-quarter earnings briefing.
Perrigo Plays To OTC Strength With GoodSense Firm Acquisition
Geiss, Destin & Dunn's GoodSense brand includes more than 1,500 OTC drugs and nutritional products. The deal could help diminish the impact of earnings headwinds on Perrigo's branded consumer health and Rx generic topicals businesses.